NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing

ELMSFORD, N.Y.–(BUSINESS WIRE)–NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, today announced that, on August 30, 2022, the Company received notice from the Nasdaq Listing Qualifications Staff (the “Staff”) indicating that, based upon the Company’s continued non-compliance with Nasdaq’s minimum bid price … [Read more…]

Pioneering Radiology Center Opens in New Jersey, Announces ImageCare Radiology

JEFFERSON, N.J.–(BUSINESS WIRE)–#3DMammogram–A pioneering, state-of-the-art radiology center in New Jersey has officially announced its opening date to the public this month. Set to improve and redefine the medical diagnostic imaging experience for its patients, the new ImageCare Radiology location in Jefferson was launched on September 1, 2022 and will provide the most advanced medical diagnostic … [Read more…]

WHO Backs Safer Sex Against Monkeypox, says AHF

LOS ANGELES–(BUSINESS WIRE)–The World Health Organization (WHO) recommended the use of condoms as a means of preventing potential monkeypox infections this week, following reports that viral DNA has been found in semen. The guidance comes several weeks after AIDS Healthcare Foundation first highlighted the importance of barrier protection for high-risk groups to reduce the risk … [Read more…]

Mental Health America of the MidSouth Supports National Suicide Prevention Awareness Month

If you or a loved one are in crisis, call 988. NASHVILLE, Tenn.–(BUSINESS WIRE)–#mentalhealth–Mental Health America of the MidSouth screening tools can help prevent a crisis. Suicide is the ninth leading cause of death in Tennessee, and major depression is the psychiatric diagnosis most associated with suicide. If you or a loved one are in … [Read more…]

Vertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 to <24 months

-With this approval, approximately 300 children with two copies of the F508del mutation will have a medicine to treat the underlying cause of their disease for the first time- BOSTON–(BUSINESS WIRE)–Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved expanded use of ORKAMBI® (lumacaftor/ivacaftor) to include children with cystic … [Read more…]

Oak Hill Bio to Participate in Citi 17th Annual BioPharma Conference

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oak Hill Bio (“Oak Hill”), a clinical-stage neonatology and rare disease therapeutics company developing life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases, today announced that members of its senior leadership team will participate in one-on-one meetings with investors at the upcoming Citi 17th Annual BioPharma Conference taking place … [Read more…]

Amylyx Pharmaceuticals Announces Posting of Briefing Documents for Second FDA Advisory Committee Meeting on AMX0035

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) (“Amylyx or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) posted briefing documents for the reconvened Peripheral and Central Nervous System Drugs Advisory Committee (PCNSDAC) meeting to review the New Drug Application (NDA) for AMX0035 (sodium phenylbutyrate and taurursodiol [also known as ursodoxicoltaurine]) for … [Read more…]

For the Community: Mental Health Monday and Faith Fridays with UHSM

UHSM Shares Mental and Spiritual Wellness with Nationwide Audiences NORFOLK, Va.–(BUSINESS WIRE)–Unite Health Share Ministries™ (UHSM), a nonprofit, faith-based healthcare sharing ministry supporting a community of Christian believers through member-to-member healthcare sharing, introduced two initiatives meant to enhance and bring awareness to members’ wellness: #MentalHealthMonday and #FaithFridays. Partnering with mental health expert and advocate Brittney … [Read more…]

Know Labs Provides Update on IRB-Approved Internal Trial of Non-Invasive Glucose Monitoring Technology

SEATTLE–(BUSINESS WIRE)–Know Labs, Inc. (OTCQB: KNWN), an emerging developer of non-invasive medical diagnostic technology, today released a video update on the IRB-approved internal trial the Company has been conducting at its laboratory in Seattle. The video can be found here. The two-minute video breaks down the trial process, while Know Labs Chief Product Officer Steve … [Read more…]

CARsgen Releases the First Clinical Batch of CAR T Cells from its RTP GMP Manufacturing Facility in North Carolina

SHANGHAI–(BUSINESS WIRE)–CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that the company’s Current Good Manufacturing Practice (CGMP) manufacturing facility located at the Research Triangle Park (RTP) in North Carolina, the United States of America (“The RTP GMP Manufacturing … [Read more…]